跳至主要内容
临床试验/RBR-4frcs6
RBR-4frcs6招募中未知

The use of clobazam vs clonazepam as adjuvants in the treatment of focal epilepsy: effectiveness and adverse effects

niversidade Federal de Pernambuco0 个研究点开始时间: 2019年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 —(—)

入选标准

  • Diagnosis of focal epilepsy according to ILAE classification;
  • Focal epilepsy with at least 1 epileptic seizure every 2 months, in current use of monotherapy or polytherapy;
  • Age above 18 years;
  • Regularity and attendance at scheduled appointments.

排除标准

  • Comorbidities such as severe kidney or liver disease that prevent the use of therapy proposed by the study;
  • Use one of two study drugs, namely clobazam or clonazepam.

研究者

发起方
niversidade Federal de Pernambuco

相似试验